New study seeks better ways to track prostate cancer without extra surgery
NCT ID NCT06144619
First seen Nov 16, 2025 · Last updated Apr 24, 2026 · Updated 19 times
Summary
This study looks at 500 men with prostate cancer to find non-invasive biomarkers—like substances in blood or urine—that can show if the disease is getting worse. Participants continue their normal care, including biopsies and scans, and also give extra blood and urine samples. The goal is to improve how doctors monitor prostate cancer without relying solely on invasive procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.